High-risk merchant account for nutraceutical and supplement brands with a Mauritius company

We begin with a thorough profile review of your Mauritius GBC, assessing your business model, product registrations, and any existing processing history. This includes analysing MCC 5499, chargeback ratios, and UBO details.

Our team then builds a robust underwriting file, detailing website compliance, clear refund policies, and a transparent billing descriptor. We address specific risk drivers such as continuity billing and health claims by ensuring all marketing materials meet regulatory standards. We match your GBC to acquirer types licensed for both the nutraceutical MCC and Mauritius entities, making warm introductions and managing Q&A with underwriters post-submission.

Underwriters scrutinise several key areas. They require comprehensive KYC/KYB on all Ultimate Beneficial Owners and directors of the Mauritius GBC. Six months of processing statements are essential, demonstrating chargeback and refund ratios. For nutraceuticals, they also examine product ingredient lists, proof of product registration where applicable, and detailed billing and cancellation flows.

Website and checkout compliance are paramount, alongside evidence of robust fulfilment and delivery processes. For Mauritius GBCs, proof of local substance – such as resident directors, a local bank account, and management in Mauritius – is also verified to meet regulatory expectations. Your management company's confirmation is typically required.

Mauritius Global Business Companies (GBCs) are well-suited for international trade, offering flexibility for nutraceutical brands targeting global markets. However, their GBC licence and constitutional documents are crucial for underwriting. The Financial Services Commission (FSC) and Registrar of Companies oversee these entities.

Local substance requirements for GBCs, including resident directors and a local bank account, are key considerations for financial institutions. While local banks onboard GBCs, often via the management company, specialist international acquirers are generally preferred for high-risk card processing. Audited accounts filed with the FSC are a standard reporting requirement that underwriters will expect.

High-risk nutraceutical accounts often get declined due to inadequate compliance documentation, unrealistic health claims, or high chargeback rates, especially from free-trial models. For Mauritius GBCs, a lack of clear local substance or incomplete entity documentation can also lead to rejection.

We prevent this by meticulously preparing your file, ensuring all product registrations are in order and marketing samples are compliant. We help you refine billing flows and refund policies to mitigate chargeback risk. By verifying the GBC licence, management company confirmation, and substance proof, we address jurisdictional concerns upfront, proactively resolving potential red flags before submission to our network of international acquirers.

The typical timeline for securing a live high-risk merchant account for a Mauritius nutraceutical GBC ranges from 2 to 6 weeks once a complete file is submitted. This includes the initial review, file preparation, introductions to acquirers, and their internal underwriting.

Post-approval, the acquirer will establish reserves and rolling limits, typically indicative of the industry’s risk profile. Xavion also advises on ongoing chargeback monitoring strategies and compliance best practices to maintain account health. We ensure your Mauritius GBC remains compliant with both local regulations and the acquirer’s terms, helping you sustain processing capabilities long-term.